SKINĒDIT AGELESS — B2B Dossier
SKINĒDIT AGELESS
01 / 20
SKINĒDIT Ageless Portrait
Chapter I — The Surface Illusion

The Portrait
of the
Surface Illusion.

You have been told that aging is a gentle, skin-deep decline. You've been given topical creams to polish the surface. You've been sold a superficial myth.

"

SKINĒDIT addresses aging not at the skin, but at the deep, underlying foundational architecture beneath it.

Target Profiles

Who is Ageless For?

An advanced systemic protocol targeted toward the physical and chemical root causes of deep facial degradation.

Post-45 Cliff
Individuals experiencing accelerated systemic collagen collapse and bone density loss post-menopause.
Drapery Sagging
Those witnessing jawline softening, falling fat pads, and loose facial contours as skeletal anchors recede.
Deep Expressions
For static nasolabial folds and deepening lines set into place by progressive dermal elastocalcinosis.
Volume Loss & Hollows
Sunken cheeks, recessed eye sockets, and structural volume reduction caused by facial bone resorption.
Loss of Snap-Back
Brittle, mineralised elastic tissues that have lost natural thickness, pliability, and rebound capacity.
Active Prevention
Ages 30+ seeking to proactively protect the bone matrix and cross-link young collagen networks.
99% UNTREATED STRUCTURAL FOUNDATION 1% TOPICAL SKINCARE EPIDERMIS 0.1mm COLLAGEN MATRIX 3–4mm
Chapter I — The Surface Illusion

The 1% Myth:
The Iceberg.

Standard skincare operates at the epidermis — a 0.1mm surface. The real aging crisis begins 3–4mm beneath the skin, at the level of the collagen matrix and the facial skeleton itself.

The Reality
Aging is non-linear. It is characterised by sudden, catastrophic structural shifts — cliffs — that occur deep within the facial anatomy where no topical can reach.
Mature face Skull Structure
Chapter I — The Surface Illusion
What lies beneath every expression line

Your face loses
its scaffolding.

Sagging, hollowing, and deepening lines are not the story. They are symptoms. As the scaffold beneath your skin recedes, the tissue above has nothing left to hold onto.

It drifts. It drapes. It loses its address.

"

Observe the structural synchronization: the bone foundation beneath dictates the visual outcome on the surface.

THE CLIFF 100% 50% 0% Age 25 45 55 75 SKELETAL MATRIX COLLAGEN MESH
Chapter I — The Surface Illusion

The Post-45
Freefall.

At age 45, protective hormonal support declines. Normal physiological aging accelerates into a rapid, unanchored structural collapse — collagen drops by 30% in just five years.

Age BracketCollagen LossBone Resorption
Ages 25–45 Baseline−1.0% / yr−0.3% / yr
Ages 45–55 The Cliff Phase−6.0% / yr−3.0% / yr
Ages 55+ Late Stage−2.0% / yr−1.0% / yr
01
02
03
Chapter I — The Surface Illusion

The Cranial
Shift.

The facial skeleton undergoes predictable bone resorption within three structural zones. As these contours recede, soft tissue loses its scaffold and pools downward.

01

Orbital Widening

The eye socket recedes upward and outward. This widens and deepens the under-eye hollow, dropping the brows and creating tear-trough shadows.
02

Maxillary Retreat

The upper jaw recedes backward. Without this bone ledge, mid-face fat pads slide forward and downward, deepening nasolabial folds dramatically.
03

Mandibular Collapse

The lower jaw loses height and horizontal length. As this perimeter shrinks, excess skin pools along the jaw, forming jowls.
Chapter II — The Mineral Sabotage

The calcium
that leaves
your bones
settles into
your skin.

As bone density declines, calcium doesn't disappear. It migrates — binding to the elastic fibers deep within the dermis, making them rigid, brittle, incapable of rebound.

The dry, fixed lines this creates cannot be hydrated away. They are mineralised.

Elastocalcinosis Microscopy
Elastocalcinosis Microscopy (500×)
Chapter II — The Mineral Sabotage

Pathological
Petrification.

This is Elastocalcinosis — migrated calcium binds directly to the elastic fibres of the dermis. Skin that should be soft and springy becomes chemically petrified, brittle and dry.

The MGP Redirect Loop
As soft tissues calcify, K2VITAL® DELTA triggers the activation of Matrix Gla Protein (MGP) — a powerful calcium traffic controller that actively extracts calcium deposits from the skin matrix and channels them back to reinforce skeletal framework density.
AGELESS Reverses This Cascade
By clearing mineral blockage, elastin fibers are restored to natural rebound, unlocking hard expression lines from deep in the dermis.
Chapter II — The Mineral Sabotage

Enzymatic
Demolition.

UV rays and oxidative stress activate Matrix Metalloproteinases (MMPs) — destructive cellular "scissors" that sever the remaining dry, calcified collagen fibres.

UV & Oxidative Stress Level
NONE 0% CRITICAL
Collagen Repair Lattice 8K
Chapter II — Enzymatic Demolition

MMPs: The
Biological Scissors.

Matrix Metalloproteinases (MMPs) act as destructive cellular enzymes. Triggered by UV rays and free radical stress, these "molecular scissors" target and slice through the calcified, rigid collagen and elastin fibres of the dermis.

Skeletal Collapse Correlation
When MMP scissors cut the collagen mesh while the skull base below experiences bone resorption, facial volume loss accelerates into an unanchored downward slide.
Part II — System Blueprint

AGX-3™ Engine:
Rebuild & Redirect.

A synergistic, bone-deep protocol designed to counteract skeletal degradation and capture migrating calcium deposits.

K2VITAL® DELTA Traffic Controller

Activates crucial osteocalcin proteins to clear calcified blockages from elastic skin tissues, redirecting the minerals deep into the skeletal bones.

Mesoporosil® Silicium Architect

380x more soluble. Triggers osteoblast differentiation to synthesize a healthy, fresh collagen scaffolding directly onto the facial bone structures.

Vitamin D3 Catalyst

Essential absorption co-factor that secures loose minerals permanently into the bone matrix, optimizing craniofacial volume preservation.

COLLAGEN CROSS-LINKING MODEL
Part II — The Intervention

NanoLift™:
Reinforce & Cross-Link.

A deep-reaching dermal mesh designed to cross-link fresh collagen fibers into a dense structural array, preventing skin folds from permanently setting into place.

Dermal Binding Synergy
Recharges mechanical support elements, preventing the "drift" of surface expressions.
Part II — Cellular Defence

The Longevity
Shield.

Astaxanthin
6,000× more potent than Vitamin C. Paralyses MMP enzymes that destroy collagen. 21-hour systemic half-life for sustained protection.
L-Ergothioneine
Activates SIRT1 → FOXO-3, the body's master switch for cellular lifespan. Repairs DNA and triggers autophagy — cellular debris removal.
CoQ10 + Alpha-Lipoic Acid
Triggers mitochondrial biogenesis for sustained ATP production. Powers the collagen synthesis machinery from the inside out.
Lutein — Internal UV Filter
Filters high-energy blue light and UV radiation at the cellular level before photo-oxidative cascades can destroy dermal integrity.
Activate AGELESS Shield
Complete Protocol
AGELESS: The Vertical Synergy.
Lab Proven Origination:
Norway 🇳🇴 Belgium 🇧🇪 France 🇫🇷
Skeletal Engine / AGX-3™
K2VITAL® DELTA 🇳🇴 Patented
Activates MGP to clear soft-tissue deposits and route calcium back to bones.
Mesoporosil® 🇧🇪 Patented
Premium highly soluble silicium. Drives cellular bone-collagen scaffolding production.
Vitamin D3
Ensures permanent mineral lock-in inside the structural face frame.
Dermal Engine / NanoLift™
Vitis Vinifera 🇫🇷
Potent antioxidant that shields fragile dermal microvessels and inhibits matrix decay.
Ceramosides® 🇫🇷 Patented
Locks lipids together to decrease transepidermal water loss.
Copper & Zinc Bisglycinates
Chelated minerals that activate cross-linking LOX enzymes to bind collagen fibers together.
Longevity Shield
Astaxanthin
Neutralises MMP molecular scissors to arrest enzymatically triggered collagen loss.
L-Ergothioneine
Enters mitochondria to stimulate key SIRT1 longevity pathways.
CoQ10 & Lutein
Shields tissues from UV oxidative damage while maximizing baseline cell energy.
Clinical Trial Dashboard — COMPLIFE® Italy
33 Women 90 Days
UP TO
-0%
Wrinkle Depth
-11.2% study average
Cutometer · p<0.001
UP TO
+0%
Hydration
+29.4% study average
Corneometer · p<0.001
UP TO
+0%
Elasticity
+3.2% study average
Cutometer R2 · p<0.05
Instrumental Efficacy Details
Structural Redensification (Wrinkle Depth) UP TO -0% (Avg: -0%)
Dermal Matrix Saturation (Hydration) UP TO +0% (Avg: +0%)
Skin Elasticity (R2 Gross Elasticity) UP TO +0% (Avg: +0%)
Skin Firmness (R0 Distensibility) UP TO -0% (Avg: -0%)
Self-Assessment (90 Days)
Firmer
0%
Smoother
0%
Contours
0%
Youthful
0%
SKINĒDIT Ageless Face Structure
PRIMOS Day 0
Day 0 — Baseline
PRIMOS Day 90
Day 90 — Protocol
Part III — Clinical Proof

3D Dermal
Profilometry.

PRIMOS optical scanning measures physical wrinkle topography in sub-micron depth — objective instrument data, zero subjectivity.

Day 0 Baseline −300 µm depth Brittle, calcified fibres form deep structural crevices.
Day 90 Protocol −110 µm depth Newly cross-linked collagen pushes the valley floor upward by 63%.
IMPROVEMENT
63%
Reduction in wrinkle depth
Quality & Compliance

Scientific Standards
of Excellence.

Made in France
Formulated and manufactured under precise laboratory conditions in Paris
GMP
GMP Certified
Manufactured in full compliance with global Good Manufacturing Practices
Victoire de la Beauté
Victoire de la Beauté
Winner of the prestigious French blind-test beauty innovation jury award 2025–26
100%
Vegan Formula
Plant-derived matrix. Zero animal elements, gelatin, or synthetic flowing agents
0%
Zero Fillers
No magnesium stearate, no silicon dioxide, no chemical excipients whatsoever
CL
COMPLIFE® Vetted
Clinical outcomes independently certified by COMPLIFE® Analytical Division, Italy
Scientific Evidence

The Peer-Reviewed Evidence Base.

I. Facial Skeleton & Bone Resorption

Shaw, R.B., et al. (2011). "Aging of the Facial Skeleton: Aesthetic Implications and Rejuvenation Strategies." Plastic and Reconstructive Surgery.

Mendelson, A.A., et al. (2012). "Age Related Changes of the Facial Skeleton: An Anatomical and Surgical Review." Aesthetic Surgery Journal.

Shuster, S. (2009). "Osteoporosis, a unitary hypothesis of collagen loss in skin and bone." Medical Hypotheses.

Boskey, A.L. (2013). "Bone Composition: Relationship to Bone Fragility." Bonekey Reports.

II. AGX-3™ Matrix (Silicium & K2)

Hannu, K., et al. (2018). "From dissolution to dermal benefits: in vitro, ex vivo, and in vivo evaluation of mesoporosil." CosmosDerma.

Nobile, A., Hannu, K., et al. (2023). "Efficacy and safety of mesoporosil treatment in enhancing skin firmness." CosmosDerma.

Siddiqui, G.S., et al. (2018). "Mesoporosil: A Novel Silicon Delivery System with Superior Bioavailability." Journal of Medicinal Food.

Reffitt, D.M., et al. (2003). "Orthosilicic acid stimulates collagen type I synthesis." Bone.

Takaishi, M., et al. (2016). "Matrix Gla Protein: A Calcium Binding Protein." Journal of Biological Chemistry.

Sayama, Y., et al. (2020). "Elastocalcinosis: Calcium Deposition in Elastic Fibers." Dermatology.

Knapen, M.H.J., et al. (2018). "Menaquinone-7 supplementation improves arterial stiffness." Thrombosis and Haemostasis.

Simon, D.C., et al. (2019). "Vitamin K as a Powerful Micronutrient in Aging." International Journal of Molecular Sciences.

III. NanoLift™ Complex (Dermal & Lipid)

Guen, C., et al. (2024). "Dietary supplementation with a wheat polar lipid complex." Journal of Cosmetic Dermatology.

Watt, V., et al. (2017). "Improving skin hydration and age-related symptoms." Cosmetics.

Camera, E., et al. (2019). "Ceramosides®: Phytoceramides for Skin Hydration." International Journal of Cosmetic Science.

Hachmouli, M.H. & Grant, S. (2014). "The structure, function, and importance of ceramides in skin." Journal of the American Academy of Dermatology.

IV. Longevity Shield (Antioxidant & Defence)

Davinelli, S., et al. (2018). "Astaxanthin in Skin Health, Repair, and Disease." Nutrients.

Ho, N., et al. (2019). "The protective role of astaxanthin for uv-induced skin deterioration." Nutrients.

Suganuka, K., et al. (2010). "Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1." Journal of Dermatological Science.

Solana, K., et al. (2014). "L-Ergothioneine protects skin cells against UV-induced damage." Cosmetics.

Chang, D., et al. (2022). "The Effects of L-ergothioneine on skin hydration, elasticity." Current Trends on Biotechnology & Microbiology.

Haza, Y.C., et al. (2020). "The Anti-aging Activity of Ergothioneine in UVA-Irradiated Human Dermal Fibroblasts." Oxidative Medicine and Cellular Longevity.

Cheah, I.K. & Halliwell, B. (2012). "Ergothioneine: antioxidant potential, physiological function." Biochimica et Biophysica Acta.

Palombo, P., et al. (2007). "Beneficial long-term effects of combined oral/topical antioxidant treatment with lutein." Skin Pharmacology and Physiology.

Dmiteli, N., et al. (2014). "The effect of dietary intake of coenzyme Q10 on skin parameters." BioFactors.

Sommer, A.T., et al. (2021). "Vitamin D in Skin Aging." International Journal of Molecular Sciences.

SKINĒDIT Ageless Product
Chapter VI — Systemic Restoration

The Ageless
Paradigm.

SKINĒDIT AGELESS addresses volume loss and tissue sagging at their physical, internal origins instead of treating them as surface issues.

Mineral Realignment

Redirects loose calcium from calcifying skin tissues back into the bone matrix, preventing elastocalcinosis.

Bone Scaffolding Density

Combats facial bone resorption by actively supporting and strengthening the underlying structural skeletal frame of the skull.

Collagen Mesh Synthesis

Triggers healthy, fresh collagen generation and structural cross-linking from deep inside.

Enzymatic Protection

Inhibits aggressive, collagen-degrading MMP "cellular scissors" to defend the skin framework from environmental and internal decay.

A visible lift, anchored from deep within.